GR20010300072T1 - Use of effectors of the central cholinergic nervous system - Google Patents

Use of effectors of the central cholinergic nervous system

Info

Publication number
GR20010300072T1
GR20010300072T1 GR20010300072T GR20010300072T GR20010300072T1 GR 20010300072 T1 GR20010300072 T1 GR 20010300072T1 GR 20010300072 T GR20010300072 T GR 20010300072T GR 20010300072 T GR20010300072 T GR 20010300072T GR 20010300072 T1 GR20010300072 T1 GR 20010300072T1
Authority
GR
Greece
Prior art keywords
effectors
nervous system
central cholinergic
cholinergic nervous
central
Prior art date
Application number
GR20010300072T
Other languages
English (en)
Inventor
Peter Fischer
Original Assignee
Sanochemia Pharmazeutika Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanochemia Pharmazeutika Ag filed Critical Sanochemia Pharmazeutika Ag
Publication of GR20010300072T1 publication Critical patent/GR20010300072T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
GR20010300072T 1998-11-27 2001-12-31 Use of effectors of the central cholinergic nervous system GR20010300072T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT199598 1998-11-27
PCT/AT1999/000284 WO2000032185A1 (de) 1998-11-27 1999-11-22 Verwendung von effektoren des zentralen cholinergen nervensystems zur behandlung des deliriums

Publications (1)

Publication Number Publication Date
GR20010300072T1 true GR20010300072T1 (en) 2001-12-31

Family

ID=3525562

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010300072T GR20010300072T1 (en) 1998-11-27 2001-12-31 Use of effectors of the central cholinergic nervous system

Country Status (9)

Country Link
EP (1) EP1133290B1 (el)
JP (1) JP4422342B2 (el)
AU (1) AU768331B2 (el)
CA (1) CA2352564C (el)
DE (1) DE59904564D1 (el)
ES (1) ES2168240T3 (el)
GR (1) GR20010300072T1 (el)
NZ (1) NZ512546A (el)
WO (1) WO2000032185A1 (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10301851A1 (de) * 2003-01-17 2004-07-29 Lts Lohmann Therapie-Systeme Ag Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel
AT414125B (de) * 2003-09-29 2006-09-15 Sanochemia Pharmazeutika Ag Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln
MXPA05005570A (es) * 2003-09-29 2005-10-18 Sanochemia Pharmazeutika Ag Uso de galantamina y los derivados de la misma en la produccion de medicamentos.
US20080114027A1 (en) * 2006-11-09 2008-05-15 Johnson Kirk W Method for treating delirium

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0821957A3 (en) * 1996-08-01 1998-04-22 Eli Lilly And Company Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline) for treating substance abuse
EP0934040A1 (en) * 1996-10-23 1999-08-11 Eli Lilly And Company Method for treating dementia due to aids
EP0952826B1 (en) * 1997-01-17 2001-11-14 Takeda Chemical Industries, Ltd. Idebenone containing combination agent for treating alzheimer's disease

Also Published As

Publication number Publication date
WO2000032185A1 (de) 2000-06-08
CA2352564A1 (en) 2000-06-08
EP1133290A1 (de) 2001-09-19
JP2002531401A (ja) 2002-09-24
ES2168240T1 (es) 2002-06-16
NZ512546A (en) 2002-11-26
EP1133290B1 (de) 2003-03-12
ES2168240T3 (es) 2003-11-16
CA2352564C (en) 2009-05-19
DE59904564D1 (de) 2003-04-17
JP4422342B2 (ja) 2010-02-24
AU1252900A (en) 2000-06-19
AU768331B2 (en) 2003-12-11

Similar Documents

Publication Publication Date Title
GB9800795D0 (en) Prevention of multiple use of limited use devices
PL330847A1 (en) Plant gene of p-hydroxyphenylpyrogronianic dioxygenase
EP1063990A4 (en) THERAPY FOR ESTROGEN RELATED DISORDERS
EP0816503A4 (en) ALPHA-1-6 FUCOSYL TRANSFERASES
EP1017980A4 (en) METHOD FOR IDENTIFYING PHARMACEUTICALLY ACTIVE COMPOUNDS
GB2335026B (en) Dephlegmator
GB2341180A9 (en) Compounds on the basis of polyalkyl-1-oxa diazaspirodecane compounds
FR2776660B1 (fr) Diazepino-indoles de phosphodiesterases iv
GB9816556D0 (en) Therapy
DE69825324D1 (en) Thermokopf und thermodrucker
GR20010300072T1 (en) Use of effectors of the central cholinergic nervous system
GB9816897D0 (en) Therapeutic use
GB9812662D0 (en) Therapeutic use
GB0010496D0 (en) Treatment of conditions of the central nervous system
TW371925U (en) Structure of the caster
GB9811624D0 (en) Therapeutic use
GB9806039D0 (en) Therapy
GB9812664D0 (en) Therapeutic use
SI1068199T1 (en) N-aryloxyethyl-indoly-alkylamines for the treatment of depression
TW376188U (en) Structure of the transformer
TW396919U (en) Improved structure of the screw-gun
GB9821677D0 (en) Purification procedure
SI0751939T1 (en) Naphthylamides as central nervous system agents
SI1133290T1 (en) Use of inhibitors of acetylcholinesterase for the treatment of deliriums
TW380680U (en) Improved structure of the revolving-horse-lamp